Paul H. Ehrlich
Impact in
- Reproductive Medicine top 5%
- Hypothalamic control of reproductive hormones
- Hepatology top 5%
- Hepatitis C virus research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 22
-
- Cell Adhesion Molecules Research 5
- Co-authors
- William R. MoyleZeinab A. MoustafaR E CanfieldLars ÖstbergBharat JasaniKeith G HardingDavid P. BerrySteven Birken
- Journals
- The Journal of Immunology (5 papers)Biochemistry (4 papers)Plastic & Reconstructive Surgery (4 papers)Molecular Immunology (3 papers)Human Antibodies (2 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Paul H. Ehrlich
49 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 112
- Reproductive Medicine 233
- Hepatology 176
- Radiology, Nuclear Medicine and Imaging 470
- Rehabilitation 125
- Immunology 283
Countries citing papers authored by Paul H. Ehrlich
This map shows the geographic impact of Paul H. Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul H. Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul H. Ehrlich more than expected).
Fields of papers citing papers by Paul H. Ehrlich
This network shows the impact of papers produced by Paul H. Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul H. Ehrlich. The network helps show where Paul H. Ehrlich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul H. Ehrlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical characterization of BAY 73-4506: A kinase inhibitor with broad spectrum antitumor activity targeting oncogenic and angiogenic kinases | 2007 | 5 |
| 2 | 2005 | 22 | |
| 3 | 2002 | 26 | |
| 4 | 1998 | 4 | |
| 5 | 1998 | 2 | |
| 6 | 1998 | 24 | |
| 7 | 1998 | 144 | |
| 8 | 1994 | 11 | |
| 9 | 1992 | 4 | |
| 10 | 1992 | 143 | |
| 11 | 1992 | 38 | |
| 12 | 1991 | 25 | |
| 13 | 1991 | 9 | |
| 14 | Human and primate monoclonal antibodies for in vivo therapy. | 1988 | 16 |
| 15 | 1987 | 26 | |
| 16 | 1985 | 20 | |
| 17 | 1984 | 13 | |
| 18 | 1984 | 88 | |
| 19 | 1982 | 10 | |
| 20 | 1982 | 133 |
About Paul H. Ehrlich
Paul H. Ehrlich is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Reproductive Medicine, Immunology and Developmental Biology, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (22 papers), Protein purification and stability (10 papers), Glycosylation and Glycoproteins Research (9 papers), DNA and Nucleic Acid Chemistry (6 papers), Hepatitis B Virus Studies (5 papers), Hypothalamic control of reproductive hormones (5 papers), Cell Adhesion Molecules Research (5 papers) and Blood properties and coagulation (4 papers). The work is most often cited by research in Reproductive Medicine (233 citations), Hepatology (176 citations), Radiology, Nuclear Medicine and Imaging (470 citations), Rehabilitation (125 citations) and Immunology (283 citations). Paul H. Ehrlich has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include William R. Moyle, Zeinab A. Moustafa, R E Canfield, Lars Östberg, Bharat Jasani, Keith G Harding, David P. Berry, Steven Birken, Eileen Armstrong and Robert E. Canfield. Their work appears in journals such as The Journal of Immunology, Biochemistry, Plastic & Reconstructive Surgery, Molecular Immunology and Human Antibodies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.